OS
Clinical trials for OS explained in plain language.
Never miss a new study
Get alerted when new OS trials appear
Sign up with your email to follow new studies for OS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New aggressive treatment strategy tested for rare adult sinus cancer
Disease control ENROLLING_BY_INVITATIONThis study is testing a combination treatment approach for adults with a rare cancer called rhabdomyosarcoma in the nasal cavity and sinuses. The treatment involves chemotherapy, radiation therapy, and surgery in a specific sequence. Researchers want to see how well this approach…
Matched conditions: OS
Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated Apr 02, 2026 02:42 UTC
-
New combination therapy aims to reduce recurrence in rare lymphoma
Disease control ENROLLING_BY_INVITATIONThis study is testing whether adding the immunotherapy drug tislelizumab to standard chemotherapy and radiation can better control early-stage NK/T-cell lymphoma and reduce the chance of the cancer coming back. The trial will enroll 60 adults with stage I or II disease who haven'…
Matched conditions: OS
Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC